Publications | USF Parkinson's Disease and Movement Disorders Center

2015

Investigators, Writing Group for the NINDS Exploratory Trials in Parkinson Disease, K Kieburtz, BC Tilley, JJ Elm, D Babcock, RA Hauser, and . 2015. “Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease: A Randomized Clinical Trial. JAMA 2015;313:584-93.”. JAMA.

Bega, D, S Kim, Y Zhang, J Elm, J Schneider, R Hauser, A Fraser, and T Simuni. 2015. “Predictors of Functional Decline in Early Parkinson’s Disease: NET-PD LS1 Cohort. J Parkinsons Dis 2015;5:773-82.”. J Parkinsons Dis.

Hauser, RA, F Stocchi, O Rascol, SB Huyck, R Capece, TW Ho, P Sklar, C Lines, D Michelson, and D Hewitt. 2015. “Preladenant As an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned. JAMA Neurol 2015;72:1491-500.”. JAMA Neurol.

Simon, DK, C Wu, BC Tilley, AM Wills, MJ Aminoff, J Bainbridge, RA Hauser, et al. 2015. “Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine. Clin Neuropharmacol 2015:38:163-9.”. Clin Neuropharmacol.

O’Brien, CF, R Jimenez, RA Hauser, SA Factor, J Burke, D Mandri, and JC Castro-Gayol. 2015. “NBI-98854, a Selective Monoamine Transport Inhibitor for the Treatment of Tardive Dyskinesia: A Randomized, Double-Blind, Placebo-Controlled Study. Mov Disord 2015;30:1681-7.”. Mov Disord.

Hauser, RA. 2015. “α-Synuclein in Parkinson’s Disease: Getting to the Core of the Matter. Lancet Neurol 2015;14:785-6.”. Lancet Neurol.

Pahwa, R, CM Tanner, RA Hauser, K Sethi, S Isaacson, D Truong, L Struck, et al. 2015. “Amantadine Extended Release for Levodopa-Induced Dyskinesia in Parkinson’s Disease (EASED Study). Mov Disord 2015;30:788-95.”. Mov Disord.

Wechsler, R, RA Hauser, and J French. 2015. “Who Is Helping Whom? Manuscript Support and Transfer of Value. Ann Neurol 2015;77:353-5.”. Ann Neurol.

“Hauser RA. How to Dose Carbidopa and Levodopa Extended Release Capsules (Rytary). Clinical Medicine Journal 2015;1:34-7.”. 2015. Clinical Medicine Journal.

Poewe, W, RA Hauser, and A Lang. 2015. “Effects of Rasagiline on the Progression of Nonmotor Scores of the MDS-UPDRS. Mov Disord 2015;30:589-92.”. Mov Disord.